Zenobe Gramme S.A (ZEN) | Stock Overview & Key Data

Frequently Asked Questions

What is ZEN's 52-week high and low?

In the last 52 weeks, Zenobe Gramme S.A reached a high of €216.00 (on March 17, 2025) and a low of €185.00 (on June 11, 2024).

What is the market cap and P/E ratio for ZEN?

Curious about Zenobe Gramme S.A's size and valuation? Its market capitalization stands at 13.14M. When it comes to valuation, the P/E ratio (trailing twelve months) is 1,247.06, and the forward P/E (looking ahead) is N/A.

Does ZEN pay dividends? If so, what's the yield?

As for dividends, Zenobe Gramme S.A isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Zenobe Gramme S.A's main competitors or similar companies to consider before investing?

When looking at Zenobe Gramme S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Nyxoah S.A NYXH	252.65M	Healthcare	Medical Instruments & Supplies	-7.79%	-36.92%
Solvac S.A SOLV	1.87B	Healthcare	Medical Instruments & Supplies	-20.55%	-7.02%
Argenx SE ARGX	29.50B	Healthcare	Biotechnology	39.26%	51.84%
Fagron NV FAGR	1.60B	Healthcare	Drug Manufacturers - Specialty & Generic	23.59%	35.27%
Ion Beam IBAB	363.48M	Healthcare	Medical Devices	-8.53%	-17.43%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Zenobe Gramme S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Zenobe Gramme S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.00%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for ZEN?

Looking at Zenobe Gramme S.A's growth, its revenue over the trailing twelve months (TTM) was €2M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of ZEN stock is held by insiders and institutions?

Wondering who owns Zenobe Gramme S.A stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 3.62%.

For more common questions about our data, please visit our About Data page.